Hiroshi Kaetsu
Kyushu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroshi Kaetsu.
Biochemistry | 2008
Masayoshi Souri; Hiroshi Kaetsu; Akitada Ichinose
Factor XIII (FXIII) is a heterotetramer composed of two catalytic A subunits (FXIII-A) and two B subunits (FXIII-B). FXIII-B has 10 Sushi domains. To explore the structure-function relationship of FXIII-B, we looked for domains in FXIII-B responsible for its homodimer and heterotetramer assembly with FXIII-A. Full-length recombinant human FXIII-B (rFXIII-B) and truncated rFXIII-Bs with various numbers of Sushi domains (rFXIII-B x- y ) were expressed in a baculovirus expression system. rFXIII-B was indistinguishable from purified human plasma FXIII-B, in terms of the molecular weight (after being deglycosylated by glycosidases) and the ability to form complexes between the two subunits. rFXIII-B was in dimer form and produced a heterotetramer complex with FXIII-A. Gel-filtration and FXIII-A binding analysis of the various truncated forms of rFXIII-B x- y revealed that the first Sushi domain was responsible for the binding of FXIII-B to FXIII-A and that the fourth and ninth Sushi domains were involved in the FXIII-B homodimer assembly. rFXIII-B and rFXIII-B 1-9, which formed a heterotetramer complex with FXIII-A, protected FXIII-A from proteolytic digestion. These findings suggest that only full-length or nearly full-length FXIII-B is large enough to cover the exposed surface of FXIII-A. In conclusion, at least 3 out of the 10 Sushi domains of FXIII-B have the distinct function of forming a homodimer and a heterotetramer, which should be ascribed to the differences in their amino acid sequences. The present studies, however, do not exclude the possibility that additional Sushi domains may also support either or both functions.
Thrombosis Research | 1998
Hiroshi Kaetsu; Jun Mizuguchi; Takayoshi Hamamoto; Koichiro Kamimura; Yasuko Yoshida; Tomohiro Nakagaki; Yoichi Ogata; Seiji Miyamoto; Akinobu Funatsu
We investigated the ability of polyethylene glycol 4000 to accelerate thrombin generation in a mixture of prothrombin and factor X at concentrations of 1-30%. In the presence of 5 mM of CaCl2, polyethylene glycol 4000 promoted prothrombin activation at concentrations above 1%. The peak of activation was seen at levels of 14 and 20% of polyethylene glycol 4000. The effect of the polyethylene glycol was remarkably dependent on its molecular weight; molecular weights greater than 2000 were required for accelerating thrombin generation. Under optimal conditions, polyethylene glycol 4000, in the presence of CaCl2, promoted conversion of all of the prothrombin into thrombin and its derivatives. We conclude that polyethylene glycol 4000, at concentrations ranging from 14 to 20%, effectively accelerates thrombin generation in the presence of 5 mM of CaCl2. This new method for preparing thrombin is based on the use of polyethylene glycol 4000 and CaCl2 and is applicable to the manufacture of thrombin.
Journal of Biochemistry | 1996
Hiroshi Kaetsu; Teruto Hashiguchi; Don Foster; Akitada Ichinose
Journal of Biochemistry | 1988
Takashi Morita; Hiroshi Kaetsu; Jun Mizuguchi; Shun-ichiro Kawabata; Sadaaki Iwanaga
Archive | 1997
Hiroshi Kaetsu; Jun Mizuguchi; Takayoshi Hamamoto
Archive | 1996
Hiroshi Kaetsu; Yoichi Ogata; 洋 嘉悦; 洋一 緒方
Archive | 1997
Takayoshi Hamamoto; Hiroshi Kaetsu; Jun Mizuguchi
Japanese Journal of Thrombosis and Hemostasis | 1999
Koichiro Kamimura; Hiroshi Kaetsu; Jun Mizuguchi
Archive | 1998
Takayoshi Hamamoto; Hiroshi Kaetsu; Kouichirou Kamimura; Jun Mizuguchi; 晃一朗 上村; 洋 嘉悦; 純 水口; 高義 濱本
Japanese Journal of Thrombosis and Hemostasis | 1998
Hiroshi Kaetsu; Jun Mizuguchi